Keros Therapeutics KROS
NASDAQ KROS
$11.35 +0.17 (+1.52%)
At close: Oct 22, 2026 · 4:00 PM EDT

Keros Therapeutics (KROS) Other financing activities (2020 - 2025)

Updated

Keros Therapeutics (KROS) recorded Other financing activities of $420,000 in FY2020.

Analysis

Keros Therapeutics (KROS) Other financing activities (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Keros Therapeutics 224.56 Mn -1.70 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 139,000.00
Dec 31, 2024 -171,000.00
Jun 30, 2024 -24,000.00
Mar 31, 2024 -259,000.00
Dec 31, 2023 -94,000.00
Dec 31, 2022 -87,000.00
Dec 31, 2020 -193,000.00
Jun 30, 2020 -2.56 Mn
Mar 31, 2020 -219,000.00
API Access

Keros Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=KROS&period=max&api_key=YOUR_API_KEY